Literature DB >> 2204130

Research into the results of resection of hilar bile duct cancer.

E J Boerma1.   

Abstract

We found mentions of 581 resections of hilar bile duct cancer in the literature to January 1989. Resection in 499 patients, reported or updated since 1980, resulted in an operative mortality of 12% and a 5-year survival rate of 13%. Resections confined to the hepatic duct confluence or extended to the quadrate lobe led to an 8% operative mortality and a 7% 5-year survival rate, although resections combined with major liver resection gave a 15% operative mortality and a 17% 5-year survival rate. Despite the best treatments available, present-day resection modalities are usually still not radical. Extension of resection in the retrohilar and hepatoduodenal direction might further improve the long-term surgical results.

Entities:  

Mesh:

Year:  1990        PMID: 2204130

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  41 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Changing trends of surgical treatment of hilar bile duct cancer: clinical and experimental perspectives.

Authors:  Zhi-Qiang Huang; Ning-Xin Zhou; Da-Dong Wang; Jian-Guo Lu; Ming-Yi Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

3.  Palliation of malignant obstructive jaundice--surgery or stent?

Authors: 
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

4.  Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer.

Authors:  Tatsuharu Yamada; Toshiyuki Arai; Masato Nagino; Koji Oda; Junichi Shoda; Hiroshi Suzuki; Yuichi Sugiyama; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-06-17       Impact factor: 3.445

Review 5.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

6.  Outcome of surgical treatment of hilar cholangiocarcinoma.

Authors:  Kazuhiro Otani; Kazuo Chijiiwa; Masahiro Kai; Jiro Ohuchida; Motoaki Nagano; Kazuyo Tsuchiya; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

7.  Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Authors:  Ryoko Sasaki; Yuichiro Takeda; Osamu Funato; Hiroyuki Nitta; Hidenobu Kawamura; Noriyuki Uesugi; Tamotsu Sugai; Go Wakabayashi; Nobuhiro Ohkohchi
Journal:  World J Surg       Date:  2007-07-25       Impact factor: 3.352

8.  Letters to the editor.

Authors:  A J Russell; M Rees
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

9.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

10.  Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.

Authors:  Yasuji Seyama; Keiichi Kubota; Keiji Sano; Tamaki Noie; Tadatoshi Takayama; Tomoo Kosuge; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.